SPONTANEOUS PRODUCTION OF CYTOKINES IN THE SUPERNATANTS OF CELLS ISOLATED FROM PERIPHERAL BLOOD, LYMPH NODES, SPLEEN, THYMUS AND SKIN IN A MODEL OF ACUTE PSORIASIS-LIKE DERMATITIS IN MICE



Cite item

Full Text

Abstract

Imiquimod-induced model of psoriasis in mice are used for the study of psoriasis. Imiquimod in the form of skin applications  triggers a complex multi-stage process simulating psoriatic inflammation of the skin, accompanied by a change in cytokine production. The aim of this work was a comprehensive study of the production of cell supernatants isolated from skin, blood, from central and peripheral lymphoid organs and the effect of imiquimod on it. 46 mice of the C57BL/6 line were divided into two groups - control, n-22 and experimental, n-24. The formation of experimental pathology was carried out by the method of L. van der Fits. Mice of the experimental group were given a cream with 5% imiquimod (62.5 mg/cm2/day/mouse) for 7 days. On the 7th day of the experiment, blood samples were taken, the spleen, lymph nodes, thymus were extracted, and skin biopsy was obtained. To obtain a cell suspension, biopsies of the spleen, lymph nodes, and thymus were crushed in a homogenizer, and then passed through cell fittings. The method of spontaneous migration was used to isolate cells from the skin. The culture of blood, spleen, lymph nodes, thymus, and skin cells was incubated for 24 hours in RPMI-1640, then spontaneous cytokine production was investigated. The cytokine level (INF-γ, IL-1β, IL-5, IL-6, IL-10, IL-17, TNF-α, IL-10) was determined using the Mouse Th1/Th2/Th17 Panel test system. The study revealed that cells isolated from blood and lymphoid organs synthesize increased amounts of pro-inflammatory cytokines: IL-1 and IL-17. The most pronounced changes in the cytokine profile are observed in the blood, skin and spleen supernatants.

About the authors

Elina Altafovna Akhmatova

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera».

Email: ela.150@yandex.ru

Junior researcher at the Laboratory of therapeutic Vaccines

г.Москва, Малый Казённый переулок, 5а

Ekaterina Vyacheslavovna Sorokina

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: sorokina-cathrine@yandex.ru
ORCID iD: 0000-0002-1188-6578
SPIN-code: 1052-6474

Doctor of Medical Sciences, Professor, Head of the Laboratory of mechanisms of regulation of immunity

Russian Federation, Moscow, Maly Kazenny lane, 5a

Vera Nikolaevna Stolpnikova

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: stolpnikova@yandex.ru

Candidate of Biological Sciences, leading researcher at the Laboratory of mechanisms of regulation of Immunity

Eugene Olegovich Kalinichenko

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: gladius.domini@gmail.com

Candidate of Medical Sciences, researcher at the Laboratory of mechanisms of regulation of immunity

Irina Bisheva

Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова».

Email: ibisheva@yandex.ru
ORCID iD: 0000-0002-8143-7356
SPIN-code: 9846-1006

researcher at the Laboratory of mechanisms of regulation of immunity

Russian Federation

Svetlana Anatolyevna Skhodova

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Author for correspondence.
Email: skhodova2009@yandex.ru

Candidate of Biological Sciences, leading researcher at the Laboratory of mechanisms of regulation of immunity

References

  1. Bozrova S. V. , Levitsky V. A., Nedospasov S. A., Drutskaya M. S. Imiquimod: The biochemical mechanisms of immunomodulatory and anti-inflammatory activity. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2013,Vol. 7, pp.136–145.
  2. Zhukov A.S. , Lavrov N.V. , KhairutdinovV.R. , SamtsovA.V. Models of psoriasis on laboratory animals: current status of the problem. Immunologiya, 2019, 40 (2), pp. 64–9.
  3. KamilovF.H., Mufazalova N.A.,
  4. Kapuler O.M.,
  5. Razumnaja F.G., Mufazalova L.F. CYTOKINE IMBALANCE IN THE IMMUNOPATHOGENE-SIS OF PSORIASIS.
  6. FUNDAMENTAL RESEARCH, 2015, No 1, pp. 1065-1071.
  7. Kruglova L.S., Moiseev S.V. Inhibition of interkeukin-17 – new horizons of efficacy and safety in the treatment of psoriasis. Clin. Pharmacol. Ther., 2017, 26 (2), pp. 5-12.
  8. Merkushova E.D., Khasanova E.M., Gankovskaya L.V. Mechanisms of innate immunity in pathogenesis of psoriasis: approaches to targeted therapy. Medical Immunology (Russia)/Meditsinskaya Immunologiya, 2020, Vol. 22, no. 3, pp. 449-458.
  9. Patrushev A. V., Sukharev A. V., Nikitin V. Yu., Ivanov A. M., Sukhina I. A., Gumilevskaya O.P.. INFLUENCE OF FOCAL INFECTION ON THE CYTOKINE PROFILE IN PATIENTS WITH CHRONIC DERMATOSIS. Russian Journal Of Immunology, 2019;95(3), pp.16–24.
  10. Pinegin B.V., Ivanov O.L., Pinegin V.B. THE ROLE OF IMMUNE CELLS AND CYTOKINES IN THE DEVELOPMENT OF PSORIASIS. RUSSIAN JOURNAL OF SKIN AND VENEREAL DISEASES, 2013, №3, pp. 19-25.
  11. Sennikova S.V., Toptygina A.P., Semikina E.L., Zakirov R.Sh., Akulova S.S. Mononuclear subsets and cytokine profile of venous and capillary blood in patients with psoriasis and healthy people. Medical Immunology (Russia)/Meditsinskaya Immunologiya, 2021, Vol. 23, no. 6, pp. 1333-1346.
  12. Simbirtsev A.S., Totolyan A.A. CYTOKINES IN LABORATORY DIAGNOSTICS. INFECTIOUS DISEASES: news, opinions, training, 2015, №2, pp. 82-98.
  13. Smirnov V.S., Kudryavtseva T.A. Vartocide(imihimod). St. Petersburg: Hippocrates, 2017. -144p.
  14. Bubna A.K. Imiquimod - its role in the treatment of cutaneous malignancies. Indian J Pharmacol , 2015, 47(4): 354-9.
  15. P. Michael Conn. Animal models for the study of human disease. London, Academic Press, 2017, 1200 p.
  16. Richters C.D., Hoekstra M.J., du Pont J.S., Kreis R.W., Kamperdijk EW. Isolation of human skin dendritic cells by in vitro migration. Methods Mol Med., 2001, Vol. 64, pp.145-53.
  17. Shuangshuang Zhang , Xiangdong Liu , Lihong Mei , Hongfeng Wang. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice // BMC Complementary and Alternative Medicine, 2016, 16: 334.
  18. Van der Fits L, Mourits S, Voerman JSA, et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. J Immunol. 2009;182(9):5836–45.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Akhmatova E.A., Sorokina E.V., Stolpnikova V.N., Kalinichenko E.O., Bisheva I., Skhodova S.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies